Your browser doesn't support javascript.
loading
Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway.
Xu, Wen-Fei; Ma, Yi-Cong; Ma, Hou-Shi; Shi, Long; Mu, Hang; Ou, Wen-Bin; Peng, Jie; Li, Ting-Ting; Qin, Tianyi; Zhou, Hai-Meng; Fu, Xue-Qi; Li, Xu-Hui.
Afiliación
  • Xu WF; College of Life Sciences, Jilin University, Changchun, China.
  • Ma YC; Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, China.
  • Ma HS; Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, China.
  • Shi L; Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, China.
  • Mu H; Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, China.
  • Ou WB; Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, China.
  • Peng J; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China.
  • Li TT; Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Qin T; Department of Geriatric Gastroenterology, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Zhou HM; Department of Biology, Georgetown Preparatory School, North Bethesda, USA.
  • Fu XQ; Zhejiang Provincial Key Laboratory of Applied Enzymology, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, China.
  • Li XH; College of Life Sciences, Jilin University, Changchun, China.
Cell Cycle ; 18(24): 3472-3490, 2019 Dec.
Article en En | MEDLINE | ID: mdl-31713447
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Resistencia a Antineoplásicos / Proteína 1 de Unión a la Caja Y / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Cycle Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Resistencia a Antineoplásicos / Proteína 1 de Unión a la Caja Y / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Cycle Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos